Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist within the CardioVascular Institute at Beth Israel Deaconess Medical Center (BIDMC). He is also the Section Head of Interventional Cardiology and Vascular Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. He received his medical degree from Northwestern University's Feinberg School of Medicine as part of the combined BA/MD pathway and a Master’s of Science in Epidemiology from the Harvard School of Public Health. Dr. Secemsky completed his internal medicine training at the University of California, San Francisco (UCSF), and Cardiovascular Medicine, Interventional Cardiology, and Vascular Diagnostics and Intervention training all at Massachusetts General Hospital (MGH)/Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease. Dr. Secemsky leads the interventional cardiology and vascular research program at the Smith Center for Outcomes Research in Cardiology. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on the treatment of peripheral vascular disorders. Dr. Secemsky is also involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by the National Institutes of Health (NIH), FDA, Harvard Medical School, extramural grants and philanthropy. Dr. Secemsky has authored more than 270 publications and has mentored numerous medical students, residents, fellows and junior faculty. He is an Associate Editor at Vascular Medicine and is on the Editorial Boards at Circulation: Cardiovascular Interventions and JSCAI. He was a writing member of the 2024 ACC/AHA Guideline on the Management of Lower Extremity Peripheral Artery Disease (PAD), and is a writing member of the upcoming ACC/AHA Guideline on the Management of Pulmonary Embolism. He serves as the Co-Chair of SCAI's Vascular Disease Council and is on the Board of Directors for the VIVA Foundation, the Society for Vascular Medicine, and the PERT Consortium.